Eledon Pharmaceuticals, Inc. (ELDN) financial statements and ratios from SEC XBRL. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Price / Book | 8.46 |
| Sector P/E (Healthcare) | 21.7 |
ELDN overview · ELDN earnings · ELDN KPIs · ELDN investor relations · ELDN ownership · ELDN peers · ELDN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.